SCHEMBL7280550

SCHEMBL7280550

C=C1C(=C)[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@H]1CCOC(=O)OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.52
LMNA P02545 9/20 0.52
ALDH1A1 P00352 6/20 0.52
MAPT P10636 6/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
TSHR P16473 5/20 0.52
NR3C1 P04150 5/20 0.52
PGR P06401 5/20 0.52
MAPK1 P28482 4/20 0.52
SHBG P04278 4/20 0.52
SERPINA6 P08185 4/20 0.52
AR P10275 4/20 0.52
CYP2C9 P11712 3/20 0.52
NR1I2 O75469 3/20 0.52
GPBAR1 Q8TDU6 3/20 0.52
SIGMAR1 Q99720 3/20 0.52
HIF1A Q16665 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CYP2C19 P33261 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275154 0.87 LMNA (0.53) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL7236930 0.85 CYP3A4 (0.55) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL4885690 0.85 CYP3A4 (0.55) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL10957754 0.84 CYP3A4 (0.54) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
Potassium Ion SCHEMBL10957761 0.83 CYP3A4 (0.53) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL4876809 0.83 CYP3A4 (0.55) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL4907194 0.79 PSEN1 (0.47) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL11684717 0.79 LMNA (0.68) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL3747281 0.74 CYP17A1 (0.56) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL3744154 0.74 CYP17A1 (0.56) CYP3A4LMNAALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0122232-A1 20-Spiroxanes and analogues with open ring E, process for their preparation and pharmaceutical compositions CIBA-GEIGY AG (CH) 1984-10-17 EP disclosed